Filing Details

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

SCHEDULE 13G/A

Amendment No. 2

 

Under the Securities Exchange Act of 1934

Pacific Biosciences of California, Inc.

---

(Name of Issuer)

 

Common Stock

---

(Title of Class of Securities)

 

69404D108

---

(CUSIP Number)

 

December 31, 2017

---

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (the “Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

---

 

 

* Calculated based on a total of 116,249,978 shares of common stock outstanding as of October 31, 2017, as reported by the Issuer in the Quarterly Report.

 

1	NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)   Oracle Institutional  Partners, L.P.
2	CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)   (a)  ☐ (b)  ☐
3	SEC USE ONLY
4	CITIZENSHIP OR PLACE OF ORGANIZATION   Delaware
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH:		5	SOLE VOTING POWER   0
		6	SHARED VOTING POWER   838,818
		7	SOLE DISPOSITIVE POWER   0
		8	SHARED DISPOSITIVE POWER   838,818
9	AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON   838,818
10	CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)   ☐
11	PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)   0.72%*
12	TYPE OF REPORTING PERSON (See Instructions)   PN

 

This Amendment No. 2 to the Schedule 13G (this “Amendment No. 2”) is being filed with respect to the Common Stock, par value $.001 (“Common Stock”) of Pacific Biosciences of California, Inc., a Delaware corporation (the “Issuer”), amends and supplements the Schedule 13G originally filed with the United States Securities and Exchange Commission (the “SEC”) on September 15, 2016, as previously amended by Amendment No. 1 filed on February 6, 2017 (as so amended, the “Schedule 13G”). This Amendment No. 2 is being filed on behalf of Oracle Partners, LP, a Delaware limited partnership (“Oracle Partners”), Oracle Ten Fund Master, LP, a Cayman Islands exempted company (“Oracle Ten Fund”), Oracle Institutional Partners, LP, a Delaware limited partnership (“Institutional Partners” and, collectively with Oracle Partners and Oracle Ten Fund, the “Oracle Entities”), Oracle Investment Management, Inc. Employees’ Retirement Plan, an employee benefit plan organized in Connecticut (the “Retirement Plan”), Oracle Associates, LLC, a Delaware limited liability company and the general partner of Oracle Partners, Oracle Ten Fund and Institutional Partners (“Oracle Associates”), Oracle Investment Management, Inc., a Delaware corporation and the investment manager to Oracle Ten Fund and the Retirement Plan (the “Investment Manager”), The Feinberg Family Foundation, a foundation organized in Connecticut (the “Foundation”), and Larry N. Feinberg, the managing member of Oracle Associates, the sole shareholder, director and president of the Investment Manager and the trustee of the Foundation (each of the foregoing, a “Reporting Person” and collectively, the “Reporting Persons”). Capitalized terms used but not defined herein have the meaning ascribed thereto in the Schedule 13G.

Item 4. Ownership:

Item 4 of the Schedule 13G is hereby amended and restated as follows:

  

A. Larry N. Feinberg

(a) Amount beneficially owned: 8,453,375

(b) Percent of class: 7.27%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 575,000

(ii) Shared power to vote or direct the vote: 7,878,375

(iii) Sole power to dispose or direct the disposition: 575,000

(iv) Shared power to dispose or direct the disposition: 7,878,375

B. Oracle Partners

(a) Amount beneficially owned: 5,683,437

(b) Percent of class: 4.89%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 5,683,437

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 5,683,437

C. Institutional Partners

(a) Amount beneficially owned: 838,818

(b) Percent of class: 0.72%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 838,818

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 838,818

 

D. Oracle Ten Fund

(a) Amount beneficially owned: 1,124,620

(b) Percent of class: 0.97%

(c) Number of shares as to which such person has:

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 1,124,620

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 1,124,620

	ORACLE PARTNERS, L.P.
	By:  ORACLE ASSOCIATES, LLC, its general partner
	By:  /s/ Larry N. Feinberg                                           Larry N. Feinberg, Managing Member
	ORACLE TEN FUND PARTNERS, LP
	By:  ORACLE ASSOCIATES, LLC, its general partner
	By:  /s/ Larry N. Feinberg                                           Larry N. Feinberg, Managing Member
	ORACLE INSTITUTIONAL PARTNERS, LP
	By:  ORACLE ASSOCIATES, LLC, its general partner
	By:  /s/ Larry N. Feinberg                                           Larry N. Feinberg, Managing Member
	ORACLE INVESTMENT MANAGEMENT, INC. EMPLOYEES’ RETIREMENT PLAN
	By:  /s/ Larry N. Feinberg                                            Larry N. Feinberg, Trustee